MYC and acute myeloid leukemia: Su et al. observed that R-2-hydroxyglutarate (R-2HG) attenuated FTO activity and augmented global m6A modification in R-2HG-sensitive AML cells, which decreased the stability of Cebpa/Myc mRNA and the activities of relevant cell signalling pathways (Su et al., 2018).